HSD11B2: 11-beta-hydroxysteroid dehydrogenase type 2

Key regulator of cortisol metabolism and mineralocorticoid receptor specificity

Gene Information Card

Symbol HSD11B2
Full Name hydroxysteroid 11-beta dehydrogenase 2
Gene Type protein-coding
Chromosomal Location 16q22.1
NCBI Gene ID 3291 ncbi.nlm.nih.gov/gene/3291
Ensembl ID ENSG00000131669
UniProt ID P80365
OMIM ID 614232
HGNC ID 5210
Aliases AME, AME1, HSD11K, SDR9C3

Description

The HSD11B2 gene encodes 11-beta-hydroxysteroid dehydrogenase type 2, an enzyme that converts active cortisol to inactive cortisone. This protects the mineralocorticoid receptor from cortisol binding, ensuring aldosterone specificity. Mutations cause apparent mineralocorticoid excess (AME), leading to hypertension and hypokalemia.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Apparent mineralocorticoid excess (AME) Loss-of-function mutations reduce cortisol inactivation, allowing cortisol to activate mineralocorticoid receptors, causing sodium retention, hypertension, and hypokalemia. OMIM #218030; multiple case reports
Hypertension, salt-sensitive Reduced HSD11B2 activity (genetic or acquired) impairs renal cortisol clearance, contributing to salt-sensitive hypertension. ClinVar; association studies
Preeclampsia Placental HSD11B2 deficiency may increase fetal cortisol exposure, linked to hypertensive disorders of pregnancy. NCBI Gene; literature review

Expression Profile

Tissue Expression
Tissue nTPM level
Kidney 12.5 High
Colon 8.3 Medium
Placenta 6.1 Medium
Salivary gland 4.2 Low
Liver 0.8 Not detected
Cell Line Expression
Cell Line nTPM Notes
HEK 293 15.2 High expression
Caco-2 9.8 Medium expression
HepG2 1.1 Low expression
HeLa 0.5 Not detected
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.662C>T (p.Arg221*) Nonsense Rare Loss of function; truncated protein
c.1061C>T (p.Pro354Leu) Missense Rare Reduced enzyme activity
c.944G>A (p.Arg315His) Missense Rare Impaired cortisol oxidation
c.1A>G (p.Met1?) Start loss Rare No protein synthesis
Mutation functional classification

Loss of Function (LOF)

Most HSD11B2 mutations are loss-of-function, reducing or abolishing cortisol-to-cortisone conversion, leading to apparent mineralocorticoid excess.

Gain of Function (GOF)

Not reported for HSD11B2.

Dominant Negative (DN)

Not reported for HSD11B2.

Gene Ontology (GO)

• 11-beta-hydroxysteroid dehydrogenase activity (GO:0003845) NAD binding (GO:0051289)
androgen biosynthetic process (GO:0006702) estrogen biosynthetic process (GO:0006703)
female pregnancy (GO:0007565) • excretion (GO:0007588)
regulation of blood pressure (GO:0008217) cell differentiation (GO:0030154)
hormone metabolic process (GO:0042445) • oxidation-reduction process (GO:0055114)

Pathways

Corticosteroid metabolism (Reactome: R-HSA-196071)
Metabolism of steroids (Reactome: R-HSA-8957322)
Aldosterone-regulated sodium reabsorption (KEGG: hsa04960)

Protein Summary

11-beta-hydroxysteroid dehydrogenase type 2 is a 405-amino acid membrane-bound enzyme localized to the endoplasmic reticulum. It catalyzes the NAD-dependent oxidation of cortisol to cortisone, protecting the mineralocorticoid receptor from cortisol activation. Deficiency results in apparent mineralocorticoid excess, characterized by hypertension, hypokalemia, and low renin/aldosterone levels.

Related Products

Product name Cat.No. Species Gene ID
HSD11B2 Knockout HEK293 Cell Line EDJ-KQ4939 Human 3291 Details Get a Quote
HSD11B2 Knockout HeLa Cell Line EDJ-KQ26578 Human 3291 Details Get a Quote
HSD11B2 Knockout A-549 Cell Line EDJ-KQ27789 Human 3291 Details Get a Quote
HSD11B2 Knockout HCT 116 Cell Line EDJ-KQ27790 Human 3291 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: